Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid Malignancies

Study identifier:D1532C00020

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase I, Open-Label Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid Malignancies

Medical condition

Melanoma

Phase

Phase 1

Healthy volunteers

No

Study drug

AZD6244

Sex

All

Actual Enrollment

30

Study type

Interventional

Age

18 Years +

Date

Study Start Date: 01 Jul 2008
Primary Completion Date: 01 Apr 2009
Study Completion Date: 01 Jun 2010

Study design

Allocation: Randomized
Endpoint Classification: Bio-availability Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Aug 2014 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria